PO.6.132 A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus (SLE): optimization of a lupus clinical trial designU Ranganathan, Vaishali Shah, MK Crow et al.|Unknown|2022Cited by 3